from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2470/glbO

LFCtreatmentdescriptionclass of inhibitor

-1.291

Amikacinug/mL Amikacintranslation

-0.104

Cap5-10ug/mL Capreomycintranslation

0.224

Rox10-50 ug/mL Roxithromycintranslation

0.520

SM2-5 ug/mL Streptomycintranslation

-0.432

Tet5-10 ug/mL Tetracyclinetranslation

-0.515

Rif0.2-5ug/mL Rifampicintranscription

-0.351

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.434

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.376

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.461

CPZ10-50 ug/mL Chlorpromazinerespiration

0.221

Clofazimine10-13 ug/mL Clofaziminerespiration

0.010

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.100

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.723

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.201

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.003

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.420

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.692

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.905

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.477

KCN5-20 ug/mL Potassium cyaniderespiration

-0.339

NaN30.2-2 mM Sodium aziderespiration

-0.203

Nigericin50 uM Nigericinrespiration

0.205

TRC10-150 ug/mL Triclosanrespiration

-0.592

TRZ10-25 ug/mL Thioridazinerespiration

0.384

Valinomycin0.5-10 uM Valinomycinrespiration

-1.988

ZnSO42 mM ZnSO4respiration

0.816

menadione6-10 ug/mL Menadionerespiration

-0.277

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.428

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.385

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.303

NRP_1Non-replicating persistence stage 1dosRassociated

-0.226

Amp0.2mg/mL AmpicillincellWall

-0.155

Cephalexin20-100 ug/mL CephalexincellWall

-0.195

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.521

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.783

EMB10-20 ug/mL EthambutolcellWall

0.194

Eta12-40 ug/mL EthionamidecellWall

0.160

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.359

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.767

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.487

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.226

BZA0.12 mg/mL BenzamidearomaticAmides

0.111

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.307

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.408

H2O24 mM hydrogen peroxideDNAdamaging

-0.201

Levo10 ug/mL LevofloxacinDNAdamaging

-0.151

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.211

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.173

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.147

UVUV-irradiationDNAdamaging

-0.401

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.455

Antimycin12.5-50 ug/mL Antimycin A?

-0.297

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.434

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.550

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.777

PA8240.2-2 ug/mL PA-824?

1.636

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.437

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.528

Verapamil50 uM Verapamil?

-0.658

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.412

methoxatin10-20 ug/mL Methoxatin?